You are here:
Purpose: To ensure the Western Sydney Local Health District has appropriate patient safety and clinical quality systems to monitor performance and to continuously improve patient care. The HCQC will fulfill this by following these objectives:
Chair: Professor Michael Hollands
Secretariat: Sandra Jones, Executive Assistant to Director Clinical Governance
Purpose: The Local Health District is required by the 2011 Model By-Law under the Health Services Act to establish Medical Staff Councils and a Medical Staff Executive Council.
Sponsor: Professor Chris Liddle
Purpose: The Clinical Council has been established by the WSLHD Board and Chief Executive to provide advice on clinical matters affecting the Western Sydney Local Health District as set out in the Local Health Districts model by-laws. It should be noted that the Council is established to support the WSLHD Board and Chief Executive and does not have delegated decision-making power.
The Clinical Council will be required to provide advice to the Chief Executive and District Executive on the following matters:
The Chief Executive is to ensure the Council is provided with such information, including financials and operational performance reports, as is necessary to enable it to properly undertake its functions.
Purpose: The functions of the Finance, Performance and Assets Management Committee of the Board are to oversee Western Sydney LHD’s strategic approach to finance, operational performance and capital works/assets and monitor, review and recommend actions to the Board on:
Chair: Andrew Bernard, WSLHD Board member
Executive sponsor: Barry Mitrevski, Director Finance
Secretariat: Christian Jansen
Committee members: Graeme Loy, Chief Executive
Jeremy Chapman, WSLHD Board member
Brett Thompson, General Manager Westmead & Auburn Hospital
Robynne Cooke, Executive Director Operations
Elizabeth Andersen, Deputy Director Finance
David Rogers, Independent Member
Purpose: The WSLHD Research Development Committee has been established to provide leadership for the development of research and to ensure high quality research is translated into improved clinical care in WSLHD. As a Committee of the Board, the Committee is responsible for the governance of research within the LHD and provides assurance to the Board on research activities.
Following are the responsibilities of the Research Development Committee:
Chair: Professor Jeremy Chapman AC
Secretariat: Mark T Smith, Research and Education Network
Contact Unit: Research and Education Network email@example.com
Purpose: The purpose of the Audit and Risk Committee (ARC) is to provide independent assistance to the Board and Chief Executive by monitoring, reviewing and providing advice about the organisation’s governance processes, risk management and control frameworks, and its external accountability obligations.
The Board has established an Audit and Risk Committee, with the following core responsibilities:
Chair: Allan Cook, Independent member
Executive Sponsor: Eduardo Alegado, Director Internal Audit
Secretariat: Margaret Taofi, Assistant Auditor & Executive Assistant
Carolyn Walsh, Independent member
Arthur Butler, Independent Member
Jim Mitchell, Independent Member
Loretta Di Mento, Independent Member